Katkin Keith

Katkin Keith is listed in filings as Director at Emergent Biosolutions Inc. This profile follows SEC Form 4 activity through May 4, 2026, including sale activity and purchase activity. Recent filings connect the profile to Emergent Biosolutions Inc (EBS), Syndax Pharmaceuticals, Inc. (SNDX), and Eledon Pharmaceuticals, Inc. (ELDN). The current snapshot covers public activity from Jan 13, 2025 to May 4, 2026. Reported amounts are shown as $128.2K to $49.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.